1. Home
  2. MDV vs KROS Comparison

MDV vs KROS Comparison

Compare MDV & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$18.00

Market Cap

187.5M

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.00

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDV
KROS
Founded
2015
2015
Country
United States
United States
Employees
9
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.5M
206.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MDV
KROS
Price
$18.00
$11.00
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$18.00
$21.86
AVG Volume (30 Days)
55.5K
223.5K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
7.50%
N/A
EPS Growth
N/A
146.00
EPS
N/A
N/A
Revenue
N/A
$243,864,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.56
$2,751.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.80
$9.69
52 Week High
$18.83
$22.55

Technical Indicators

Market Signals
Indicator
MDV
KROS
Relative Strength Index (RSI) 50.81 57.07
Support Level $17.60 $10.64
Resistance Level $18.75 $11.63
Average True Range (ATR) 0.37 0.44
MACD -0.13 0.12
Stochastic Oscillator 30.33 83.43

Price Performance

Historical Comparison
MDV
KROS

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in, and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from the company's consolidated real estate properties.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: